Sunflower Therapeutics Gets First Milestone Payment from SK Bioscience Read More » September 18, 2025
Ascletis Reports ASC30 Half-Life of 36 Days, Enabling Once‑Monthly Dosing Read More » September 9, 2025
Glenmark Starts Phase 3 Trial of Envafolimab for Stage III Non-Small Cell Lung Cancer Read More » September 8, 2025